» Articles » PMID: 37558446

Global Environmental Risk Factors of Schizophrenia: a Study Protocol for Systematic Review and Meta-analysis of Cohort Studies

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Aug 9
PMID 37558446
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Schizophrenia is a chronic, complex and severe psychiatric disorder affecting millions of people every year and inflicting different costs to the individual, family and community. A growing body of evidence has introduced several genetic and environmental factors and their interactions as aetiological factors of schizophrenia. The goal of this systematic review and meta-analysis is to present an updated representation of the global environmental risk factors of schizophrenia.

Method And Analysis: This protocol is developed and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guideline. We will systematically search the databases such as PubMed, Scopus, Web of Science, PsycINFO and Embase until 30 September 2022. We include Cohort studies that have reported one or more risk factors of schizophrenia. We will also search Google Scholar search engine and references lists of included articles. Extracting the relevant data and assessing the quality of the included studies will be independently performed by different authors of our team. The risk of bias for the included studies will be evaluated using Newcastle-Ottawa Scale. Subgroup analysis, meta-regression or sensitivity analysis will be our solution to deal with heterogeneity between studies. We will use a funnel diagram as well as Begg and Egger tests to check for possible publication bias.

Ethics And Dissemination: Ethical approval is not required because there will be no primary data collection or human involvement. The results of this study will be published in an international peer-reviewed journal.

Prospero Registration Number: CRD42022359327.

References
1.
Orrico-Sanchez A, Lopez-Lacort M, Munoz-Quiles C, Sanfelix-Gimeno G, Diez-Domingo J . Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain. BMC Psychiatry. 2020; 20(1):149. PMC: 7132863. DOI: 10.1186/s12888-020-02538-8. View

2.
Sipos A, Rasmussen F, Harrison G, Tynelius P, Lewis G, Leon D . Paternal age and schizophrenia: a population based cohort study. BMJ. 2004; 329(7474):1070. PMC: 526116. DOI: 10.1136/bmj.38243.672396.55. View

3.
Vaucher J, Keating B, Lasserre A, Gan W, Lyall D, Ward J . Cannabis use and risk of schizophrenia: a Mendelian randomization study. Mol Psychiatry. 2017; 23(5):1287-1292. PMC: 5984096. DOI: 10.1038/mp.2016.252. View

4.
Wicks S, Hjern A, Gunnell D, Lewis G, Dalman C . Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am J Psychiatry. 2005; 162(9):1652-7. DOI: 10.1176/appi.ajp.162.9.1652. View

5.
Wahbeh M, Avramopoulos D . Gene-Environment Interactions in Schizophrenia: A Literature Review. Genes (Basel). 2021; 12(12). PMC: 8702084. DOI: 10.3390/genes12121850. View